Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2005
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibodyEric Mirallié, Catherine Saï-Maurel, Alain Faivre-Chauvet, et al.
Molecular Immunology|October 3, 2006
Generation of llama single-domain antibodies against methotrexate, a prototypical haptenNidia Alvarez-Rueda, Ghislaine Behar, Virginie Ferré, et al.
Bioconjugate Chemistry|July 21, 2009
Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumorsFaisal Alshoukr, Cedric Rosant, Veronique Maes, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 8, 2012
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Catherine Ansquer, et al.
Cancer|February 4, 2010
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinomaPierre-Yves Salaun, Caroline Bodet-Milin, Eric Frampas, et al.
Molecular Cancer Therapeutics|December 7, 2002
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograftFrançoise Kraeber-Bodéré, Catherine Saï-Maurel, Loïc Campion, et al.
EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Generation of fluorescently labeled tracers - which features influence the translational potential?Fijs W B van Leeuwen, Bart Cornelissen, Federico Caobelli, et al.
Molecular Cancer Therapeutics|December 14, 2002
Molecular advances in pretargeting radioimunotherapy with bispecific antibodiesChien-Hsing Chang, Robert M Sharkey, Edmund A Rossi, et al.
Pharmaceutics|January 16, 2021
Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [<sup>177</sup>Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse ModelJudith Anna Delage, Alain Faivre-Chauvet, Jacques Barbet, et al.
Plos One|February 13, 2014
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodyniaMickaël Terme, Mylène Dorvillius, Denis Cochonneau, et al.
Pageof 9